Shortwave Life Sciences (AQSE:PSY) Change In Payables And Accrued Expense : £0.00 Mil (TTM As of . 20)

View and export this data going back to 2022. Start your Free Trial

What is Shortwave Life Sciences Change In Payables And Accrued Expense?

Shortwave Life Sciences's Change In Payables And Accrued Expense for the quarter that ended in . 20 was £0.00 Mil. It means Shortwave Life Sciences's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Shortwave Life Sciences's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was £0.00 Mil. It means Shortwave Life Sciences's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Shortwave Life Sciences Change In Payables And Accrued Expense Historical Data

The historical data trend for Shortwave Life Sciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shortwave Life Sciences Change In Payables And Accrued Expense Chart

Shortwave Life Sciences Annual Data

Trend

Change In Payables And Accrued Expense

Shortwave Life Sciences Semi-Annual Data

Change In Payables And Accrued Expense

Shortwave Life Sciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 was £0.00 Mil.

Shortwave Life Sciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Shortwave Life Sciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Shortwave Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shortwave Life Sciences PLC (AQSE:PSY) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.shortwavelifesciences.com

Shortwave Life Sciences PLC is a biopharmaceutical company focused in advancing pioneering therapies in mental health care, also it is involved in developing novel drug combinations and delivery methods to treat patients suffering from mental health disorders. It identifies, operates and creates value from early-stage, breakthrough initiatives, with an initial focus on eating disorders.